Blood Transfusion - 5 2020 (September-October)

Original article

Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status

Barbara Pachikian, Damien Naslain, Nicolas Benoit, Romain Brebels, Kristin Van Asch, Veerle Compernolle, Philippe Vandekerckhove, Louise Deldicque
Bacterial contamination of blood products for transfusion in the Democratic Republic of the Congo: temperature monitoring, qualitative and semi-quantitative culture

Anne-Sophie Heroes, Natacha Ndalingosu, Jocelyne Kalema, Aimée Luyindula, Dorothée Kashitu, Catherine Akele, Jeff Kabinda, Katrien Lagrou, Philippe Vandekerckhove, Jan Jacobs, Octavie Lunguya
Postoperative patient blood management: transfusion appropriateness in cancer patients

Lucia Merolle, Chiara Marraccini, Erminia Di Bartolomeo, Maria T. Montella, Thelma A. Pertinhez, Roberto Baricchi, Alessandro Bonini
Monoclonal antibody specific to the Di(a) blood group antigen generated by phage display technology

Phatchira Thattanon, Jeeraphong Thanongsaksrikul, Sawang Petvises, Oytip Nathalang
Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience

Annarita Tagliaferri, Annalisa Matichecchia, Gianna F. Rivolta, Federica Riccardi, Gabriele Quintavalle, Anna Benegiamo, Antonio Coppola
Patients’ satisfaction associated with portable coagulometers for warfarin monitoring: a cross-sectional study

Nicoletta riva, Christian Borg Xuereb, Walter Ageno, Michael Makris, Alex Gatt
Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study

Emilia Parodi, Giovanna Russo, Piero Farruggia, Lucia D. Notarangelo, Maria T. Giraudo, Margherita Nardi, Fiorina Giona, Paola Giordano, Ugo Ramenghi, and the “AIEOP-ITP Study Group” (Appendix 1)
Preliminary assessment of the new Sysmex XN parameter Iron-Def for identifying iron deficiency

Vincenzo Roccaforte, Massimo Daves, Giuseppe Lippi, Andrea Piccin, Flavia Sciarini, Vanessa Proserpio, Claudio Bonato

Editorial

Letter to the Editor

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Mehran Karimi, Sezaneh Haghpanah, Amin Shahsavani

Blood Transfusion - 5 2020 (September-October)

Original article

Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status

Bacterial contamination of blood products for transfusion in the Democratic Republic of the Congo: temperature monitoring, qualitative and semi-quantitative culture

Postoperative patient blood management: transfusion appropriateness in cancer patients

Monoclonal antibody specific to the Di(a) blood group antigen generated by phage display technology

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience

Patients’ satisfaction associated with portable coagulometers for warfarin monitoring: a cross-sectional study

Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study

Preliminary assessment of the new Sysmex XN parameter Iron-Def for identifying iron deficiency

Editorial

Oral iron and blood donation: cui bono?

Why do we overtreat children with immune thrombocytopenia despite existing evidence-based guidelines?

Letter to the Editor

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Information

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Blood Transfusion - 5 2020 (September-October)

Original article

Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status

Bacterial contamination of blood products for transfusion in the Democratic Republic of the Congo: temperature monitoring, qualitative and semi-quantitative culture

Postoperative patient blood management: transfusion appropriateness in cancer patients

Monoclonal antibody specific to the Di(a) blood group antigen generated by phage display technology

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience

Patients’ satisfaction associated with portable coagulometers for warfarin monitoring: a cross-sectional study

Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study

Preliminary assessment of the new Sysmex XN parameter Iron-Def for identifying iron deficiency

Editorial

Oral iron and blood donation: cui bono?

Why do we overtreat children with immune thrombocytopenia despite existing evidence-based guidelines?

Letter to the Editor

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Information